Phase 1 T-ALL Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
B-ALLAML/MDST-ALL+1 more
St. Jude Children's Research Hospital108 enrolled2 locationsNCT04318678
Recruiting
Phase 1
To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT
CD7+ T-ALL/LBL
Peking University People's Hospital18 enrolled1 locationNCT07280494
Recruiting
Phase 1
Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies
T-ALL/Lymphoma
Chongqing Precision Biotech Co., Ltd15 enrolled1 locationNCT06909474
Recruiting
Phase 1
CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study
T-ALLT-lymphoblastic Lymphoma
Hebei Senlang Biotechnology Inc., Ltd.9 enrolled1 locationNCT06136364
Recruiting
Phase 1
Infusion of donor-derived CMV peptide-specific CTL after allogeneic HSCT
Immune reconstitution post-allogeneic haematopoietic stem cell transplantation
Department of Haematology, Westmead Hospital12 enrolled1 locationACTRN12605000213640